The Application of Extracellular Vesicles Mediated miRNAs in Osteoarthritis: Current Knowledge and Perspective
Xiaobin Shang,1,* Yan Fang,2,* Wenqiang Xin,3 Hongbo You1 1Department of Orthopaedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China; 2Department of Anesthesiology, Tongji Hospital, Tongji Medica...
Wedi'i Gadw mewn:
Prif Awduron: | Shang X (Awdur), Fang Y (Awdur), Xin W (Awdur), You H (Awdur) |
---|---|
Fformat: | Llyfr |
Cyhoeddwyd: |
Dove Medical Press,
2022-04-01T00:00:00Z.
|
Pynciau: | |
Mynediad Ar-lein: | Connect to this object online. |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
-
Small Extracellular Vesicles' miRNAs: Biomarkers and Therapeutics for Neurodegenerative Diseases
gan: Wei Qing Lim, et al.
Cyhoeddwyd: (2023) -
Therapeutic potential of plant-derived extracellular vesicles as nanocarriers for exogenous miRNAs
gan: María-Carmen López de las Hazas, et al.
Cyhoeddwyd: (2023) -
Mechanisms of action of extracellular miRNAs
gan: A.E. Abaturov, et al.
Cyhoeddwyd: (2022) -
The Research Progress of Exosomes in Osteoarthritis, With Particular Emphasis on the Mediating Roles of miRNAs and lncRNAs
gan: Chenggui Miao, et al.
Cyhoeddwyd: (2021) -
Alpha-hederin reprograms multi-miRNAs activity and overcome small extracellular vesicles-mediated paclitaxel resistance in NSCLC
gan: Yuzhen Chang, et al.
Cyhoeddwyd: (2024)